{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:37:15Z","timestamp":1787341035477,"version":"build-2736575974"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-178260"],"award-info":[{"award-number":["PJT-178260"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Inflammation is a hallmark of breast cancer (BC), influencing the tumor microenvironment (TME), immune evasion and tumor growth. N-3 polyunsaturated fatty acids (PUFA), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have anti-inflammatory and immunomodulatory effects, potentially mediated through anti-inflammatory and immune pathways. Evidence is varied by study design, dosage, and formulations, making it difficult to identify consistent mechanisms and therapeutic potential. Therefore, this systematic review aims to provide a comprehensive assessment of the biological and mechanistic effects of n-3 PUFA on inflammation in BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was conducted on PubMed, Web of Science, and the GOED (Global Organization for EPA and DHA) Clinical Study Database to identify preclinical and clinical studies investigating the effects of n-3 PUFA on inflammation and immune function in BC. Eligible studies were selected using predefined inclusion criteria (PROSPERO CRD42024499082) and assessed for risk of bias using Cochrane Handbook guidance. Primary outcomes included changes in cytokines, tumor-infiltrating immune cells, and inflammatory signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 860 articles screened, 67 met the inclusion criteria. Across study types, n-3 PUFA demonstrated significant anti-inflammatory and anti-tumoral effects. Clinical studies showed IL-6 levels decreased by 50\u201370% with n-3 PUFA treatment. Preclinical studies reported significant reductions in proinflammatory cytokines (IL-6, TNF-\u03b1, CCL2\/MCP-1), alongside increases in non-inflammatory cytokines (IL-10, IL-2) and a 57\u201390% reduction in lipid mediators (PGE\n                      <jats:sub>2<\/jats:sub>\n                      ) and associated enzymes (COX-2) with n-3 PUFA treatment. In vitro findings showed large decreases (-40-80%) in NF-\u03baB and matrix metalloproteinase (MMP-2, -9) activity with n-3 PUFA treatment. Variability in n-3 PUFA dose, form, and outcomes was noted across studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>n-3 PUFA exhibit anti-inflammatory and immunomodulatory effects in BC, highlighting their potential as adjuvant therapies to modulate the TME. Standardized research methodologies and clinical trials are needed to clarify dose-response relationships and therapeutic applications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11912-026-01820-4","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:42:34Z","timestamp":1787294554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Omega-3 Polyunsaturated Fatty Acids in Modulating Inflammation and Breast Cancer: A Systematic Review of In Vitro, Animal, and Human Studies"],"prefix":"10.1007","volume":"28","author":[{"given":"Rahbika","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor D.C.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Monk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay E.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W. L.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"3","key":"1820_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1820_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncol. 2023;9(4):465\u201372. https:\/\/doi.org\/10.1001\/jamaoncol.2022.7826.","journal-title":"JAMA Oncol"},{"key":"1820_CR3","doi-asserted-by":"publisher","unstructured":"\u0141ukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanis\u0142awek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel). 2021;13(17). https:\/\/doi.org\/10.3390\/cancers13174287.","DOI":"10.3390\/cancers13174287"},{"issue":"1","key":"1820_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019;51(1):27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025.","journal-title":"Immunity"},{"key":"1820_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jnutbio.2021.108763","volume":"95","author":"JM Monk","year":"2021","unstructured":"Monk JM, Liddle DM, Hutchinson AL, Burns JL, Wellings H, Cartwright NM, et al. Fish oil supplementation increases expression of mammary tumor apoptosis mediators and reduces inflammation in an obesity-associated HER-2 breast cancer model. J Nutr Biochem. 2021;95:10. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108763.","journal-title":"J Nutr Biochem"},{"key":"1820_CR6","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.3390\/nu12123901","volume":"12","author":"L Hillyer","year":"2020","unstructured":"Hillyer L, Hucik B, Baracuhy E, Lin Z, Muller W, Robinson L, et al. Her-2 Breast Cancer Outcomes Are Mitigated by Consuming n-3 Polyunsaturated, Saturated, and Monounsaturated Fatty Acids Compared to n-6 Polyunsaturated Fatty Acids. Nutrients. 2020;12:3901. https:\/\/doi.org\/10.3390\/nu12123901.","journal-title":"Nutrients"},{"key":"1820_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1476-511X-13-96","volume":"13","author":"MA Leslie","year":"2014","unstructured":"Leslie MA, Abdelmagid SA, Perez K, Muller WJ, Ma DW. Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model. Lipids Health Dis. 2014;13:96. https:\/\/doi.org\/10.1186\/1476-511X-13-96.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"1820_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","volume":"21","author":"AP Simopoulos","year":"2002","unstructured":"Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495\u2013505. https:\/\/doi.org\/10.1080\/07315724.2002.10719248.","journal-title":"J Am Coll Nutr"},{"key":"1820_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jnutbio.2017.12.011","volume":"55","author":"J Liu","year":"2018","unstructured":"Liu J, Abdelmagid SA, Pinelli CJ, Monk JM, Liddle DM, Hillyer LM, et al. Marine fish oil is more potent than plant-based n-3 polyunsaturated fatty acids in the prevention of mammary tumors. J Nutr Biochem. 2018;55:41\u201352. https:\/\/doi.org\/10.1016\/j.jnutbio.2017.12.011.","journal-title":"J Nutr Biochem"},{"issue":"5","key":"1820_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3945\/an.114.007732","volume":"6","author":"M Gabbs","year":"2015","unstructured":"Gabbs M, Leng S, Devassy JG, Monirujjaman M, Aukema HM. Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. Adv Nutr. 2015;6(5):513\u201340. https:\/\/doi.org\/10.3945\/an.114.007732.","journal-title":"Adv Nutr"},{"key":"1820_CR11","doi-asserted-by":"publisher","first-page":"101605","DOI":"10.1016\/j.smim.2022.101605","volume":"59","author":"WA Julliard","year":"2022","unstructured":"Julliard WA, Myo YPA, Perelas A, Jackson PD, Thatcher TH, Sime PJ. Specialized pro-resolving mediators as modulators of immune responses. Semin Immunol. 2022;59:101605. https:\/\/doi.org\/10.1016\/j.smim.2022.101605.","journal-title":"Semin Immunol"},{"issue":"9","key":"1820_CR12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1158\/1940-6207.capr-15-0018","volume":"8","author":"NA Ford","year":"2015","unstructured":"Ford NA, Rossi EL, Barnett K, Yang PY, Bowers LW, Hidaka BH, et al. Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer. Cancer Prev Res. 2015;8(9):796\u2013806. https:\/\/doi.org\/10.1158\/1940-6207.capr-15-0018.","journal-title":"Cancer Prev Res"},{"issue":"1","key":"1820_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10787-015-0259-7","volume":"24","author":"AK Negi","year":"2016","unstructured":"Negi AK, Renuka, Bhatnagar A, Agnihotri N. Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer. Inflammopharmacology. 2016;24(1):11\u201322. https:\/\/doi.org\/10.1007\/s10787-015-0259-7.","journal-title":"Inflammopharmacology"},{"issue":"4","key":"1820_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1017\/S0029665120007077","volume":"79","author":"PC Calder","year":"2020","unstructured":"Calder PC. n-3 PUFA and inflammation: from membrane to nucleus and from bench to bedside. Proc Nutr Soc. 2020;79(4):404\u201316. https:\/\/doi.org\/10.1017\/S0029665120007077.","journal-title":"Proc Nutr Soc"},{"key":"1820_CR15","doi-asserted-by":"publisher","unstructured":"Gionfriddo G, Plastina P, Augimeri G, Catalano S, Giordano C, Barone I, et al. Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPAR\u03b3 Ligands as a Potential Target in Breast Cancer. Cells. 2020;9(1). https:\/\/doi.org\/10.3390\/cells9010174.","DOI":"10.3390\/cells9010174"},{"issue":"1","key":"1820_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1017\/S0007114522000575","volume":"129","author":"Y Guo","year":"2023","unstructured":"Guo Y, Ma B, Li X, Hui H, Zhou Y, Li N, et al. n-3 PUFA can reduce IL-6 and TNF levels in patients with cancer. Br J Nutr. 2023;129(1):54\u201365. https:\/\/doi.org\/10.1017\/S0007114522000575.","journal-title":"Br J Nutr"},{"key":"1820_CR17","doi-asserted-by":"publisher","first-page":"109104","DOI":"10.1016\/j.intimp.2022.109104","volume":"111","author":"Z Kavyani","year":"2022","unstructured":"Kavyani Z, Musazadeh V, Fathi S, Hossein Faghfouri A, Dehghan P, Sarmadi B. Efficacy of the omega-3 fatty acids supplementation on inflammatory biomarkers: An umbrella meta-analysis. Int Immunopharmacol. 2022;111:109104. https:\/\/doi.org\/10.1016\/j.intimp.2022.109104.","journal-title":"Int Immunopharmacol"},{"key":"1820_CR18","doi-asserted-by":"publisher","first-page":"100372","DOI":"10.1016\/j.phanu.2023.100372","volume":"27","author":"M Jamali","year":"2024","unstructured":"Jamali M, Zarezadeh M, Jamilian P, Ghoreishi Z. The effect of n-3 polyunsaturated fatty acids on inflammation status in cancer patients: Updated systematic review and dose- and time-response meta-analysis. PharmaNutrition. 2024;27:100372. https:\/\/doi.org\/10.1016\/j.phanu.2023.100372.","journal-title":"PharmaNutrition"},{"issue":"3","key":"1820_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1080\/01635581.2021.1931365","volume":"74","author":"L Pan","year":"2022","unstructured":"Pan L, Zhou Y, Yin H, Hui H, Guo Y, Xie X. Omega-3 Polyunsaturated Fatty Acids Can Reduce C-Reactive Protein in Patients with Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutr Cancer. 2022;74(3):840\u201351. https:\/\/doi.org\/10.1080\/01635581.2021.1931365.","journal-title":"Nutr Cancer"},{"issue":"4","key":"1820_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1158\/1940-6207.capr-17-0354","volume":"11","author":"A Gucalp","year":"2018","unstructured":"Gucalp A, Zhou XK, Cook ED, Garber JE, Crew KD, Nangia JR, et al. A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease. Cancer Prev Res. 2018;11(4):203\u201313. https:\/\/doi.org\/10.1158\/1940-6207.capr-17-0354.","journal-title":"Cancer Prev Res"},{"issue":"4","key":"1820_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/nu15041001","volume":"15","author":"S Sahye-Pudaruth","year":"2023","unstructured":"Sahye-Pudaruth S, Ma DWL. Assessing the Highest Level of Evidence from Randomized Controlled Trials in Omega-3 Research. Nutrients. 2023;15(4):1001.","journal-title":"Nutrients"},{"issue":"2","key":"1820_CR22","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00109.2021","volume":"321","author":"KM Turner","year":"2021","unstructured":"Turner KM, Yeo SK, Holm TM, Shaughnessy E, Guan JL. Heterogeneity within molecular subtypes of breast cancer. Am J Physiol Cell Physiol. 2021;321(2):C343\u201354. https:\/\/doi.org\/10.1152\/ajpcell.00109.2021.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"1820_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s43018-019-0002-1","volume":"1","author":"CA Iacobuzio-Donahue","year":"2020","unstructured":"Iacobuzio-Donahue CA, Litchfield K, Swanton C. Intratumor heterogeneity reflects clinical disease course. Nat Cancer. 2020;1(1):3\u20136. https:\/\/doi.org\/10.1038\/s43018-019-0002-1.","journal-title":"Nat Cancer"},{"issue":"2","key":"1820_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41416-021-01328-7","volume":"125","author":"F L\u00fc\u00f6nd","year":"2021","unstructured":"L\u00fc\u00f6nd F, Tiede S, Christofori G. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br J Cancer. 2021;125(2):164\u201375. https:\/\/doi.org\/10.1038\/s41416-021-01328-7.","journal-title":"Br J Cancer"},{"key":"1820_CR25","doi-asserted-by":"publisher","first-page":"102055","DOI":"10.1016\/j.tranon.2024.102055","volume":"47","author":"M Hassan","year":"2024","unstructured":"Hassan M, Tutar L, Sari-Ak D, Rasul A, Basheer E, Tutar Y. Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics. Transl Oncol. 2024;47:102055. https:\/\/doi.org\/10.1016\/j.tranon.2024.102055.","journal-title":"Transl Oncol"},{"issue":"2","key":"1820_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11626-014-9822-6","volume":"51","author":"TJ Pogash","year":"2015","unstructured":"Pogash TJ, El-Bayoumy K, Amin S, Gowda K, de Cicco RL, Barton M, et al. Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells. Vitro Cell Dev Biol Anim. 2015;51(2):121\u20137. https:\/\/doi.org\/10.1007\/s11626-014-9822-6.","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"1820_CR27","doi-asserted-by":"publisher","first-page":"102024","DOI":"10.1016\/j.plefa.2019.102024","volume":"156","author":"I Brown","year":"2020","unstructured":"Brown I, Lee J, Sneddon AA, Cascio MG, Pertwee RG, Wahle KWJ, et al. Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasion. Prostaglandins Leukot Essent Fat Acids. 2020;156:102024. https:\/\/doi.org\/10.1016\/j.plefa.2019.102024.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"2","key":"1820_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10549-005-2415-z","volume":"92","author":"PD Schley","year":"2005","unstructured":"Schley PD, Jijon HB, Robinson LE, Field CJ. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat. 2005;92(2):187\u201395. https:\/\/doi.org\/10.1007\/s10549-005-2415-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1820_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3835(91)90008-6","volume":"56","author":"UN Das","year":"1991","unstructured":"Das UN. Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett. 1991;56(3):235\u201343. https:\/\/doi.org\/10.1016\/0304-3835(91)90008-6.","journal-title":"Cancer Lett"},{"key":"1820_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122607","author":"L VanderSluis","year":"2017","unstructured":"VanderSluis L, Mazurak VC, Damaraju S, Field CJ. Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18122607.","journal-title":"Int J Mol Sci"},{"key":"1820_CR31","doi-asserted-by":"publisher","unstructured":"Newell M, Mazurak V, Postovit LM, Field CJ. N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence. Cancers (Basel). 2021;13(6). https:\/\/doi.org\/10.3390\/cancers13061206.","DOI":"10.3390\/cancers13061206"},{"issue":"6","key":"1820_CR32","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/nu15061310","volume":"15","author":"MH Theinel","year":"2023","unstructured":"Theinel MH, Nucci MP, Alves AH, Dias OFM, Mamani JB, Garrig\u00f3s MM, et al. The Effects of Omega-3 Polyunsaturated Fatty Acids on Breast Cancer as a Preventive Measure or as an Adjunct to Conventional Treatments. Nutrients. 2023;15(6):1310.","journal-title":"Nutrients"},{"key":"1820_CR33","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1820_CR34","doi-asserted-by":"publisher","first-page":"102458","DOI":"10.1016\/j.plefa.2022.102458","volume":"183","author":"AA Bernasconi","year":"2022","unstructured":"Bernasconi AA, Wilkin AM, Roke K, Ismail A. Development of a novel database to review and assess the clinical effects of EPA and DHA omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2022;183:102458. https:\/\/doi.org\/10.1016\/j.plefa.2022.102458.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1820_CR35","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"issue":"1","key":"1820_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41598-023-28411-8","volume":"13","author":"A Arsic","year":"2023","unstructured":"Arsic A, Krstic P, Paunovic M, Nedovic J, Jakovljevic V, Vucic V. Anti-inflammatory effect of combining fish oil and evening primrose oil supplementation on breast cancer patients undergoing chemotherapy: a randomized placebo-controlled trial. Sci Rep. 2023;13(1):9. https:\/\/doi.org\/10.1038\/s41598-023-28411-8.","journal-title":"Sci Rep"},{"issue":"3","key":"1820_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10549-017-4559-z","volume":"167","author":"MB Lustberg","year":"2018","unstructured":"Lustberg MB, Orchard TS, Reinbolt R, Andridge R, Pan XL, Belury M, et al. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain. Breast Cancer Res Treat. 2018;167(3):709\u201318. https:\/\/doi.org\/10.1007\/s10549-017-4559-z.","journal-title":"Breast Cancer Res Treat"},{"key":"1820_CR38","doi-asserted-by":"publisher","unstructured":"Mantha OL, Hankard R, Tea I, Schiphorst AM, Dumas JF, Berger V et al. N-3 Fatty Acid Supplementation Impacts Protein Metabolism Faster Than it Lowers Proinflammatory Cytokines in Advanced Breast Cancer Patients: Natural\u2009<SUP>15<\/SUP> N\/<SUP>14<\/SUP>\u00a0N Variations during a Clinical Trial. Metabolites. 2022;12(10):19. https:\/\/doi.org\/10.3390\/metabo12100899","DOI":"10.3390\/metabo12100899"},{"key":"1820_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12937-017-0295-9","volume":"16","author":"EMD Paixao","year":"2017","unstructured":"Paixao EMD, Oliveira ACD, Pizato N, Muniz-Junqueira MI, Magalhaes KG, Nakano EY, et al. The effects of EPA and DHA enriched fish oil on nutritional and immunological markers of treatment naive breast cancer patients: a randomized double-blind controlled trial. Nutr J. 2017;16:11. https:\/\/doi.org\/10.1186\/s12937-017-0295-9.","journal-title":"Nutr J"},{"issue":"1","key":"1820_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/01635581.2014.847964","volume":"66","author":"HL Hutchins-Wiese","year":"2014","unstructured":"Hutchins-Wiese HL, Picho K, Watkins BA, Li Y, Tannenbaum S, Claffey K, et al. High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study. Nutr Cancer. 2014;66(1):68\u201376. https:\/\/doi.org\/10.1080\/01635581.2014.847964.","journal-title":"Nutr Cancer"},{"key":"1820_CR41","doi-asserted-by":"publisher","first-page":"110025","DOI":"10.1016\/j.jnutbio.2025.110025","volume":"145","author":"J Munhoz","year":"2025","unstructured":"Munhoz J, Bigras G, Newell M, Rivas-Serna IM, Mazurak V, Goruk S, et al. The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial. J Nutr Biochem. 2025;145:110025. https:\/\/doi.org\/10.1016\/j.jnutbio.2025.110025.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"1820_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12094-018-1950-0","volume":"21","author":"N Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez N, Herrera M, Fr\u00edas L, Provencio M, P\u00e9rez-Carri\u00f3n R, D\u00edaz V, et al. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study. Clin Transl Oncol. 2019;21(4):489\u201398. https:\/\/doi.org\/10.1007\/s12094-018-1950-0.","journal-title":"Clin Transl Oncol"},{"key":"1820_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clnesp.2024.11.014","volume":"65","author":"HF Almassri","year":"2025","unstructured":"Almassri HF, Abdul Kadir A, Srour M, Foo LH. The effects of Omega-3 fatty acids and vitamin D supplementation on the quality of life and blood inflammation markers in newly diagnosed breast cancer women: An open-labelled randomised controlled trial. Clin Nutr ESPEN. 2025;65:64\u201375. https:\/\/doi.org\/10.1016\/j.clnesp.2024.11.014.","journal-title":"Clin Nutr ESPEN"},{"issue":"17","key":"1820_CR44","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1200\/jco.2014.59.5595","volume":"33","author":"DL Hershman","year":"2015","unstructured":"Hershman DL, Unger JM, Crew KD, Awad D, Dakhil SR, Gralow J, et al. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927. J Clin Oncol. 2015;33(17):1910\u20137. https:\/\/doi.org\/10.1200\/jco.2014.59.5595.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1820_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13058-025-02048-z","volume":"27","author":"J Munhoz","year":"2025","unstructured":"Munhoz J, Newell M, Goruk S, Ghosh S, Patel D, Joy AA, et al. Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial. Breast Cancer Res. 2025;27(1):91. https:\/\/doi.org\/10.1186\/s13058-025-02048-z.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"1820_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.31557\/apjcp.2019.20.3.911","volume":"20","author":"D Darwito","year":"2019","unstructured":"Darwito D, Dharmana E, Riwanto I, Budijitno S, Suwardjo S, Purnomo J, et al. Effects of Omega-3 Supplementation on Ki-67 and VEGF Expression Levels and Clinical Outcomes of Locally Advanced Breast Cancer Patients Treated with Neoadjuvant CAF Chemotherapy: A Randomized Controlled Trial Report. Asian Pac J Cancer Prev. 2019;20(3):911\u20136. https:\/\/doi.org\/10.31557\/apjcp.2019.20.3.911.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1820_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17101694","author":"A Molfino","year":"2025","unstructured":"Molfino A, Imbimbo G, Salerno G, Lionetto L, De Luca A, Simmaco M, et al. Effects of DHA Oral Supplementation on Plasma Resolvin D1 and D2 Levels in Na\u00efve Breast Cancer Patients. Cancers. 2025. https:\/\/doi.org\/10.3390\/cancers17101694.","journal-title":"Cancers"},{"key":"1820_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jnutbio.2020.108504","volume":"87","author":"CH Guo","year":"2021","unstructured":"Guo CH, Hsia SM, Chung CH, Lin YC, Shih MY, Chen PC, et al. Nutritional supplements in combination with chemotherapy or targeted therapy reduces tumor progression in mice bearing triple-negative breast cancer. J Nutr Biochem. 2021;87:12. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108504.","journal-title":"J Nutr Biochem"},{"issue":"2","key":"1820_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/carcin\/bgab106","volume":"43","author":"I Elisia","year":"2022","unstructured":"Elisia I, Yeung M, Wong J, Kowalski S, Larsen M, Shyp T, et al. A low-carbohydrate diet containing soy protein and fish oil reduces breast but not prostate cancer in C3(1)\/Tag mice. Carcinogenesis. 2022;43(2):115\u201325. https:\/\/doi.org\/10.1093\/carcin\/bgab106.","journal-title":"Carcinogenesis"},{"key":"1820_CR50","doi-asserted-by":"publisher","first-page":"106096","DOI":"10.1016\/j.jff.2024.106096","volume":"115","author":"ALA Souza","year":"2024","unstructured":"Souza ALA, Martins Trindade L, Dias Borges A, Caroline Lacerda Leocadio P, de Oliveira Silva J, Salgado Fernandes R, et al. Omega-3 fatty acid supplementation attenuates intestinal mucositis and tumor growth in a murine model of breast cancer. J Funct Foods. 2024;115:106096. https:\/\/doi.org\/10.1016\/j.jff.2024.106096.","journal-title":"J Funct Foods"},{"issue":"10","key":"1820_CR51","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1158\/1940-6207.capr-11-0175","volume":"4","author":"Z Zhu","year":"2011","unstructured":"Zhu Z, Jiang W, McGinley JN, Prokopczyk B, Richie JP Jr., Bayoumy E. Mammary gland density predicts the cancer inhibitory activity of the N-3 to N-6 ratio of dietary fat. Cancer Prev Res (Phila). 2011;4(10):1675\u201385. https:\/\/doi.org\/10.1158\/1940-6207.capr-11-0175.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"8","key":"1820_CR52","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10585-018-9941-7","volume":"35","author":"S Khadge","year":"2018","unstructured":"Khadge S, Thiele GM, Sharp JG, McGuire TR, Klassen LW, Black PN, et al. Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival. Clin Exp Metastasis. 2018;35(8):797\u2013818. https:\/\/doi.org\/10.1007\/s10585-018-9941-7.","journal-title":"Clin Exp Metastasis"},{"key":"1820_CR53","doi-asserted-by":"publisher","unstructured":"Goupille C, Vibet S, Frank PG, Mah\u00e9o K. EPA and DHA Fatty Acids Induce a Remodeling of Tumor Vasculature and Potentiate Docetaxel Activity. Int J Mol Sci. 2020;21(14). https:\/\/doi.org\/10.3390\/ijms21144965.","DOI":"10.3390\/ijms21144965"},{"issue":"3","key":"1820_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, et al. The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009;30(3):377\u201386. https:\/\/doi.org\/10.1093\/carcin\/bgp014.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1820_CR55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1042\/ebc20190083","volume":"64","author":"PC Calder","year":"2020","unstructured":"Calder PC, Eicosanoids. Essays Biochem. 2020;64(3):423\u201341. https:\/\/doi.org\/10.1042\/ebc20190083.","journal-title":"Essays Biochem"},{"issue":"1","key":"1820_CR56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41598-020-79716-x","volume":"11","author":"KM Chen","year":"2021","unstructured":"Chen KM, Thompson H, Vanden-Heuvel JP, Sun YW, Trushin N, Aliaga C, et al. Lipoxygenase catalyzed metabolites derived from docosahexaenoic acid are promising antitumor agents against breast cancer. Sci Rep. 2021;11(1):410. https:\/\/doi.org\/10.1038\/s41598-020-79716-x.","journal-title":"Sci Rep"},{"issue":"1","key":"1820_CR57","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1207\/s1532791444-49","volume":"35","author":"JM Connolly","year":"1999","unstructured":"Connolly JM, Gilhooly EM, Rose DP. Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr Cancer. 1999;35(1):44\u20139. https:\/\/doi.org\/10.1207\/s1532791444-49.","journal-title":"Nutr Cancer"},{"issue":"1","key":"1820_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0929-7855(97)00020-5","volume":"17","author":"DT Colombo","year":"1997","unstructured":"Colombo DT, Tran LK, Speck JJ, Reitz RC. Comparison of hexadecylphosphocholine with fish oil as an antitumor agent. J Lipid Mediat Cell Signal. 1997;17(1):47\u201363. https:\/\/doi.org\/10.1016\/s0929-7855(97)00020-5.","journal-title":"J Lipid Mediat Cell Signal"},{"issue":"12","key":"1820_CR59","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1194\/jlr.M042754","volume":"54","author":"Z Zou","year":"2013","unstructured":"Zou Z, Bellenger S, Massey KA, Nicolaou A, Geissler A, Bidu C, et al. Inhibition of the HER2 pathway by n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice. J Lipid Res. 2013;54(12):3453\u201363. https:\/\/doi.org\/10.1194\/jlr.M042754.","journal-title":"J Lipid Res"},{"issue":"1","key":"1820_CR60","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Therapy. 2017;2(1):17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Signal Transduct Target Therapy"},{"issue":"9","key":"1820_CR61","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/carcin\/bgi118","volume":"26","author":"SE Olivo","year":"2005","unstructured":"Olivo SE, Hilakivi-Clarke L. Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis. Carcinogenesis. 2005;26(9):1563\u201372. https:\/\/doi.org\/10.1093\/carcin\/bgi118.","journal-title":"Carcinogenesis"},{"issue":"7","key":"1820_CR62","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/jn\/131.7.2021","volume":"131","author":"LE Robinson","year":"2001","unstructured":"Robinson LE, Clandinin MT, Field CJ. R3230AC rat mammary tumor and dietary long-chain (n-3) fatty acids change immune cell composition and function during mitogen activation. J Nutr. 2001;131(7):2021\u20137. https:\/\/doi.org\/10.1093\/jn\/131.7.2021.","journal-title":"J Nutr"},{"issue":"2","key":"1820_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1023\/a:1015261111605","volume":"73","author":"LE Robinson","year":"2002","unstructured":"Robinson LE, Clandinin MT, Field CJ. The role of dietary long-chain n-3 fatty acids in anti-cancer immune defense and R3230AC mammary tumor growth in rats: influence of diet fat composition. Breast Cancer Res Treat. 2002;73(2):145\u201360. https:\/\/doi.org\/10.1023\/a:1015261111605.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"1820_CR64","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/01635581.2015.1060351","volume":"67","author":"WJ Turbitt","year":"2015","unstructured":"Turbitt WJ, Black AJ, Collins SD, Meng HC, Xu HF, Washington S, et al. Fish Oil Enhances T Cell Function and Tumor Infiltration and Is Correlated With a Cancer Prevention Effect in HER-2\/neu But Not PyMT Transgenic Mice. Nutr Cancer. 2015;67(6):965\u201375. https:\/\/doi.org\/10.1080\/01635581.2015.1060351.","journal-title":"Nutr Cancer"},{"issue":"12","key":"1820_CR65","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1158\/0008-5472.can-19-3184","volume":"80","author":"L Liu","year":"2020","unstructured":"Liu L, Jin R, Hao J, Zeng J, Yin D, Yi Y, et al. Consumption of the Fish Oil High-Fat Diet Uncouples Obesity and Mammary Tumor Growth through Induction of Reactive Oxygen Species in Protumor Macrophages. Cancer Res. 2020;80(12):2564\u201374. https:\/\/doi.org\/10.1158\/0008-5472.can-19-3184.","journal-title":"Cancer Res"},{"issue":"5","key":"1820_CR66","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00204-012-1003-3","volume":"87","author":"HW Chen","year":"2013","unstructured":"Chen HW, Chao CY, Lin LL, Lu CY, Liu KL, Lii CK, et al. Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells. Arch Toxicol. 2013;87(5):857\u201369. https:\/\/doi.org\/10.1007\/s00204-012-1003-3.","journal-title":"Arch Toxicol"},{"issue":"6","key":"1820_CR67","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/01635581.2016.1192199","volume":"68","author":"CH Chen","year":"2016","unstructured":"Chen CH, Fabian C, Hursting S, deGraffenried LA. Breast Cancer Genetic and Molecular Subtype Impacts Response to Omega-3 Fatty Acid Ethyl Esters. Nutr Cancer. 2016;68(6):1021\u201333. https:\/\/doi.org\/10.1080\/01635581.2016.1192199.","journal-title":"Nutr Cancer"},{"key":"1820_CR68","doi-asserted-by":"crossref","unstructured":"He Y, Rezaei S, J\u00fanior RFA, Cruz LJ, Eich C. Multifunctional Role of Lipids in Modulating the Tumorigenic Properties of 4T1 Breast Cancer Cells. Int J Mol Sci. 2022;23(8):4240.","DOI":"10.3390\/ijms23084240"},{"key":"1820_CR69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jnutbio.2019.108244","volume":"75","author":"A Al-Jawadi","year":"2020","unstructured":"Al-Jawadi A, Rasha F, Ramalingam L, Alhaj S, Moussa H, Gollahon L, et al. Protective effects of eicosapentaenoic acid in adipocyte-breast cancer cell cross talk. J Nutr Biochem. 2020;75:8. https:\/\/doi.org\/10.1016\/j.jnutbio.2019.108244.","journal-title":"J Nutr Biochem"},{"issue":"31","key":"1820_CR70","doi-asserted-by":"publisher","first-page":"49961","DOI":"10.18632\/oncotarget.10266","volume":"7","author":"EJ Yun","year":"2016","unstructured":"Yun EJ, Song KS, Shin S, Kim S, Heo JY, Kweon GR, et al. Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases. Oncotarget. 2016;7(31):49961\u201371. https:\/\/doi.org\/10.18632\/oncotarget.10266.","journal-title":"Oncotarget"},{"issue":"1","key":"1820_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers12010220","volume":"12","author":"F Rasha","year":"2020","unstructured":"Rasha F, Kahathuduwa C, Ramalingam L, Hernandez A, Moussa H, Moustaid-Moussa N. Combined Effects of Eicosapentaenoic Acid and Adipocyte Renin-Angiotensin System Inhibition on Breast Cancer Cell Inflammation and Migration. Cancers. 2020;12(1):17. https:\/\/doi.org\/10.3390\/cancers12010220.","journal-title":"Cancers"},{"key":"1820_CR72","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1874091x01812010130","volume":"12","author":"Z Davison","year":"2018","unstructured":"Davison Z, Nicholson RI, Hiscox S, Heard CM. Co-Administration of Fish Oil With Signal Transduction Inhibitors Has Anti-Migration Effects in Breast Cancer Cell Lines, in vitro. Open Biochem J. 2018;12:130\u201348. https:\/\/doi.org\/10.2174\/1874091x01812010130.","journal-title":"Open Biochem J"},{"issue":"4","key":"1820_CR73","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/carcin\/bgl183","volume":"28","author":"E Horia","year":"2007","unstructured":"Horia E, Watkins BA. Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells. Carcinogenesis. 2007;28(4):809\u201315. https:\/\/doi.org\/10.1093\/carcin\/bgl183.","journal-title":"Carcinogenesis"},{"issue":"4","key":"1820_CR74","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2010.10.063","volume":"402","author":"CC Mandal","year":"2010","unstructured":"Mandal CC, Ghosh-Choudhury T, Yoneda T, Choudhury GG, Ghosh-Choudhury N. Fish oil prevents breast cancer cell metastasis to bone. Biochem Biophys Res Commun. 2010;402(4):602\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2010.10.063.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1820_CR75","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jnutbio.2004.11.001","volume":"16","author":"E Horia","year":"2005","unstructured":"Horia E, Watkins BA. Comparison of stearidonic acid and alpha-linolenic acid on PGE2 production and COX-2 protein levels in MDA-MB-231 breast cancer cell cultures. J Nutr Biochem. 2005;16(3):184\u201392. https:\/\/doi.org\/10.1016\/j.jnutbio.2004.11.001.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"1820_CR76","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.plefa.2013.12.001","volume":"90","author":"M Mouradian","year":"2014","unstructured":"Mouradian M, Kikawa KD, Johnson ED, Beck KL, Pardini RS. Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth. Prostaglandins Leukot Essent Fat Acids. 2014;90(4):105\u201315. https:\/\/doi.org\/10.1016\/j.plefa.2013.12.001.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"2","key":"1820_CR77","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/bcr1980","volume":"10","author":"CV Hojilla","year":"2008","unstructured":"Hojilla CV, Wood GA, Khokha R. Inflammation and breast cancer. Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer. Breast Cancer Res. 2008;10(2):205. https:\/\/doi.org\/10.1186\/bcr1980.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1820_CR78","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52\u201367. https:\/\/doi.org\/10.1016\/j.cell.2010.03.015.","journal-title":"Cell"},{"issue":"3","key":"1820_CR79","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/jcb.29464","volume":"121","author":"M Javadian","year":"2020","unstructured":"Javadian M, Shekari N, Soltani-Zangbar MS, Mohammadi A, Mansoori B, Maralbashi S, et al. Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions. J Cell Biochem. 2020;121(3):2416\u201327. https:\/\/doi.org\/10.1002\/jcb.29464.","journal-title":"J Cell Biochem"},{"key":"1820_CR80","doi-asserted-by":"publisher","unstructured":"Ch\u00e9nais B, Cornec M, Dumont S, Marchand J, Blanckaert V. Transcriptomic Response of Breast Cancer Cells MDA-MB-231 to Docosahexaenoic Acid: Downregulation of Lipid and Cholesterol Metabolism Genes and Upregulation of Genes of the Pro-Apoptotic ER-Stress Pathway. Int J Environ Res Public Health. 2020;17(10). https:\/\/doi.org\/10.3390\/ijerph17103746.","DOI":"10.3390\/ijerph17103746"},{"key":"1820_CR81","doi-asserted-by":"publisher","unstructured":"Augimeri G, Fiorillo M, Morelli C, Panza S, Giordano C, Barone I, et al. The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment. Cancers (Basel). 2023;15(3). https:\/\/doi.org\/10.3390\/cancers15030819.","DOI":"10.3390\/cancers15030819"},{"issue":"14","key":"1820_CR82","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1096\/fj.05-3875com","volume":"19","author":"M Hill","year":"2005","unstructured":"Hill M, Pereira V, Chauveau C, Zagani R, Remy S, Tesson L, et al. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. Faseb j. 2005;19(14):1957\u201368. https:\/\/doi.org\/10.1096\/fj.05-3875com.","journal-title":"Faseb j"},{"issue":"18","key":"1820_CR83","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1089\/ars.2018.7554","volume":"30","author":"NA Gandini","year":"2019","unstructured":"Gandini NA, Alonso EN, Fermento ME, Mascar\u00f3 M, Abba MC, Col\u00f3 GP, et al. Heme Oxygenase-1 Has an Antitumor Role in Breast Cancer. Antioxid Redox Signal. 2019;30(18):2030\u201349. https:\/\/doi.org\/10.1089\/ars.2018.7554.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"1820_CR84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40795-024-00844-y","volume":"10","author":"S Maralbashi","year":"2024","unstructured":"Maralbashi S, Aslan C, Kahroba H, Asadi M, Soltani-Zangbar MS, Haghnavaz N, et al. Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells. BMC Nutr. 2024;10(1):41. https:\/\/doi.org\/10.1186\/s40795-024-00844-y.","journal-title":"BMC Nutr"},{"issue":"27","key":"1820_CR85","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1038\/onc.2014.283","volume":"34","author":"H Chung","year":"2015","unstructured":"Chung H, Lee YS, Mayoral R, Oh DY, Siu JT, Webster NJ, et al. Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancer. Oncogene. 2015;34(27):3504\u201313. https:\/\/doi.org\/10.1038\/onc.2014.283.","journal-title":"Oncogene"},{"issue":"12","key":"1820_CR86","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1096\/fj.201700033R","volume":"31","author":"HRE Dyari","year":"2017","unstructured":"Dyari HRE, Rawling T, Chen Y, Sudarmana W, Bourget K, Dwyer JM, et al. A novel synthetic analogue of \u03c9-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1\/ASK1\/JNK signaling to promote apoptosis in human breast cancer cells. Faseb j. 2017;31(12):5246\u201357. https:\/\/doi.org\/10.1096\/fj.201700033R.","journal-title":"Faseb j"},{"key":"1820_CR87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1747-1028-4-6","volume":"4","author":"ME El-Mesery","year":"2009","unstructured":"El-Mesery ME, Al-Gayyar MM, Salem HA, Darweish MM, El-Mowafy AM. Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Div. 2009;4:17. https:\/\/doi.org\/10.1186\/1747-1028-4-6.","journal-title":"Cell Div"},{"key":"1820_CR88","doi-asserted-by":"publisher","unstructured":"Guo CH, Hsia S, Chung CH, Lin YC, Shih MY, Chen PC, et al. Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice. Mar Drugs. 2021;19(4). https:\/\/doi.org\/10.3390\/md19040193.","DOI":"10.3390\/md19040193"},{"issue":"3","key":"1820_CR89","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3892\/ijo.14.3.523","volume":"14","author":"R Hamid","year":"1999","unstructured":"Hamid R, Singh J, Reddy BS, Cohen LA. Inhibition by dietary menhaden oil of cyclooxygenase-1 and \u2013\u20092 in N-nitrosomethylurea-induced rat mammary tumors. Int J Oncol. 1999;14(3):523\u20138. https:\/\/doi.org\/10.3892\/ijo.14.3.523.","journal-title":"Int J Oncol"},{"issue":"7","key":"1820_CR90","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1007\/s00394-021-02546-8","volume":"60","author":"G Ion","year":"2021","unstructured":"Ion G, Akinsete JA, Witte TR, Bostan M, Hardman WE. Maternal fish oil consumption has a negative impact on mammary gland tumorigenesis in C3(1) Tag mice offspring. Eur J Nutr. 2021;60(7):3771\u201381. https:\/\/doi.org\/10.1007\/s00394-021-02546-8.","journal-title":"Eur J Nutr"},{"issue":"4","key":"1820_CR91","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12672-011-0078-2","volume":"2","author":"A Manni","year":"2011","unstructured":"Manni A, Xu H, Washington S, Aliaga C, Das A, Cooper T, et al. The effects of Tamoxifen and fish oil on mammary carcinogenesis in polyoma middle T transgenic mice. Horm Cancer. 2011;2(4):249\u201359. https:\/\/doi.org\/10.1007\/s12672-011-0078-2.","journal-title":"Horm Cancer"},{"issue":"2","key":"1820_CR92","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/0001-3765202320210330","volume":"95","author":"NCR Da Silva","year":"2023","unstructured":"Da Silva NCR, Silva YD, Takahashi JA, Andrade SP, Cassali GD, De Oliveira DR. Dietary lipids management: are there any benefits from the prevention and treatment of 4T1 murine breast carcinoma? Acad Bras Cienc. 2023;95(2):18. https:\/\/doi.org\/10.1590\/0001-3765202320210330.","journal-title":"Acad Bras Cienc"},{"key":"1820_CR93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/1477-3163.59539","volume":"8","author":"F Alquobaili","year":"2010","unstructured":"Alquobaili F, Miller SA, Muhie S, Day A, Jett M, Hammamieh R. Estrogen receptor-dependent genomic expression profiles in breast cancer cells in response to fatty acids. J Carcinog. 2010;8:17. https:\/\/doi.org\/10.4103\/1477-3163.59539.","journal-title":"J Carcinog"},{"issue":"7","key":"1820_CR94","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1158\/1541-7786.mcr-08-0385","volume":"7","author":"JD Altenburg","year":"2009","unstructured":"Altenburg JD, Siddiqui RA. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells. Mol Cancer Res. 2009;7(7):1013\u201320. https:\/\/doi.org\/10.1158\/1541-7786.mcr-08-0385.","journal-title":"Mol Cancer Res"},{"key":"1820_CR95","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1471-2407-11-149","volume":"11","author":"JD Altenburg","year":"2011","unstructured":"Altenburg JD, Bieberich AA, Terry C, Harvey KA, Vanhorn JF, Xu Z, et al. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone. BMC Cancer. 2011;11:149. https:\/\/doi.org\/10.1186\/1471-2407-11-149.","journal-title":"BMC Cancer"},{"key":"1820_CR96","doi-asserted-by":"publisher","first-page":"118719","DOI":"10.1016\/j.lfs.2020.118719","volume":"264","author":"P Ghaffari-Makhmalbaf","year":"2021","unstructured":"Ghaffari-Makhmalbaf P, Sayyad M, Pakravan K, Razmara E, Bitaraf A, Bakhshinejad B, et al. Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesis. Life Sci. 2021;264:118719. https:\/\/doi.org\/10.1016\/j.lfs.2020.118719.","journal-title":"Life Sci"},{"issue":"1","key":"1820_CR97","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10549-006-9269-x","volume":"101","author":"R Hammamieh","year":"2007","unstructured":"Hammamieh R, Chakraborty N, Miller SA, Waddy E, Barmada M, Das R, et al. Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat. 2007;101(1):7\u201316. https:\/\/doi.org\/10.1007\/s10549-006-9269-x.","journal-title":"Breast Cancer Res Treat"},{"key":"1820_CR98","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-015-0400-7","volume":"14","author":"BN Hannafon","year":"2015","unstructured":"Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC, Ding WQ. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer. 2015;14:133. https:\/\/doi.org\/10.1186\/s12943-015-0400-7.","journal-title":"Mol Cancer"},{"issue":"1","key":"1820_CR99","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3892\/ol.2016.5382","volume":"13","author":"JK Hwang","year":"2017","unstructured":"Hwang JK, Yu HN, Noh EM, Kim JM, Hong OY, Youn HJ, et al. DHA blocks TPA-induced cell invasion by inhibiting MMP-9 expression via suppression of the PPAR-\u03b3\/NF-\u03baB pathway in MCF-7 cells. Oncol Lett. 2017;13(1):243\u20139. https:\/\/doi.org\/10.3892\/ol.2016.5382.","journal-title":"Oncol Lett"},{"issue":"1","key":"1820_CR100","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/jn\/nxy224","volume":"149","author":"M Newell","year":"2019","unstructured":"Newell M, Brun M, Field CJ. Treatment with DHA Modifies the Response of MDA-MB-231 Breast Cancer Cells and Tumors from nu\/nu Mice to Doxorubicin through Apoptosis and Cell Cycle Arrest. J Nutr. 2019;149(1):46\u201356. https:\/\/doi.org\/10.1093\/jn\/nxy224.","journal-title":"J Nutr"},{"issue":"1","key":"1820_CR101","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/s41598-018-20422-0","volume":"8","author":"N Pizato","year":"2018","unstructured":"Pizato N, Luzete BC, Kiffer L, Corr\u00eaa LH, de Oliveira Santos I, Assump\u00e7\u00e3o JAF, et al. Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells. Sci Rep. 2018;8(1):1952. https:\/\/doi.org\/10.1038\/s41598-018-20422-0.","journal-title":"Sci Rep"},{"key":"1820_CR102","doi-asserted-by":"publisher","unstructured":"Wang L, Choi HS, Lee B, Choi JH, Jang YS, Seo JW. 13R,20-Dihydroxydocosahexaenoic Acid, a Novel Dihydroxy- DHA Derivative, Inhibits Breast Cancer Stemness through Regulation of the Stat3\/IL-6 Signaling Pathway by Inducing ROS Production. Antioxid (Basel). 2021;10(3). https:\/\/doi.org\/10.3390\/antiox10030457.","DOI":"10.3390\/antiox10030457"},{"issue":"1","key":"1820_CR103","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1002\/mog2.25","volume":"2","author":"A Du","year":"2023","unstructured":"Du A, Wang Z, Huang T, Xue S, Jiang C, Qiu G, et al. Fatty acids in cancer: Metabolic functions and potential treatment. MedComm \u2013 Oncol. 2023;2(1):e25. https:\/\/doi.org\/10.1002\/mog2.25.","journal-title":"MedComm \u2013 Oncol"},{"key":"1820_CR104","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-4598-2-10","volume":"2","author":"XZ Ding","year":"2003","unstructured":"Ding XZ, Hennig R, Adrian TE. Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer. Mol Cancer. 2003;2:10. https:\/\/doi.org\/10.1186\/1476-4598-2-10.","journal-title":"Mol Cancer"},{"issue":"5","key":"1820_CR105","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1042\/bst20160474","volume":"45","author":"PC Calder","year":"2017","unstructured":"Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105\u201315. https:\/\/doi.org\/10.1042\/bst20160474.","journal-title":"Biochem Soc Trans"},{"key":"1820_CR106","doi-asserted-by":"publisher","first-page":"106351","DOI":"10.1016\/j.prostaglandins.2019.106351","volume":"144","author":"I de Bus","year":"2019","unstructured":"de Bus I, Witkamp R, Zuilhof H, Albada B, Balvers M. The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation. Prostaglandins Other Lipid mediat. 2019;144:106351. https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106351.","journal-title":"Prostaglandins Other Lipid mediat"},{"key":"1820_CR107","doi-asserted-by":"publisher","first-page":"1099811","DOI":"10.3389\/fonc.2023.1099811","volume":"13","author":"K Jin","year":"2023","unstructured":"Jin K, Qian C, Lin J, Liu B. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells. Front Oncol. 2023;13:1099811. https:\/\/doi.org\/10.3389\/fonc.2023.1099811.","journal-title":"Front Oncol"},{"issue":"3","key":"1820_CR108","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/nu2030355","volume":"2","author":"PC Calder","year":"2010","unstructured":"Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2(3):355\u201374. https:\/\/doi.org\/10.3390\/nu2030355.","journal-title":"Nutrients"},{"key":"1820_CR109","doi-asserted-by":"publisher","first-page":"595835","DOI":"10.3389\/fimmu.2020.595835","volume":"11","author":"PC Hart","year":"2020","unstructured":"Hart PC, Rajab IM, Alebraheem M, Potempa LA. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights. Front Immunol. 2020;11:595835. https:\/\/doi.org\/10.3389\/fimmu.2020.595835.","journal-title":"Front Immunol"},{"issue":"4","key":"1820_CR110","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pros.10368","volume":"59","author":"EA Platz","year":"2004","unstructured":"Platz EA, De Marzo AM, Erlinger TP, Rifai N, Visvanathan K, Hoffman SC, et al. No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer. Prostate. 2004;59(4):393\u2013400. https:\/\/doi.org\/10.1002\/pros.10368.","journal-title":"Prostate"},{"key":"1820_CR111","doi-asserted-by":"publisher","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acu\u00f1a JM, Perez-Romero BA, Guerrero-Rodriguez JF, et al. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. Int J Mol Sci. 2020;21(24). https:\/\/doi.org\/10.3390\/ijms21249739.","DOI":"10.3390\/ijms21249739"},{"issue":"5","key":"1820_CR112","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.3892\/ol.2017.6924","volume":"14","author":"H Li","year":"2017","unstructured":"Li H, Qiu Z, Li F, Wang C. The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. Oncol Lett. 2017;14(5):5865\u201370. https:\/\/doi.org\/10.3892\/ol.2017.6924.","journal-title":"Oncol Lett"},{"issue":"1","key":"1820_CR113","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12885-021-07860-2","volume":"21","author":"H Jiang","year":"2021","unstructured":"Jiang H, Li H. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):149. https:\/\/doi.org\/10.1186\/s12885-021-07860-2.","journal-title":"BMC Cancer"},{"issue":"12 Pt A","key":"1820_CR114","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.bbalip.2016.09.012","volume":"1861","author":"M Poland","year":"2016","unstructured":"Poland M, Ten Klooster JP, Wang Z, Pieters R, Boekschoten M, Witkamp R, et al. Docosahexaenoyl serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23-IL-17 signaling in macrophages. Biochim Biophys Acta. 2016;1861(12 Pt A):2020\u20138. https:\/\/doi.org\/10.1016\/j.bbalip.2016.09.012.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1820_CR115","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"key":"1820_CR116","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3389\/fimmu.2020.01167","volume":"11","author":"Y Kwon","year":"2020","unstructured":"Kwon Y, Kim M, Kim Y, Jung HS, Jeoung D. Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages. Front Immunol. 2020;11:1167. https:\/\/doi.org\/10.3389\/fimmu.2020.01167.","journal-title":"Front Immunol"},{"key":"1820_CR117","doi-asserted-by":"publisher","unstructured":"Stefanovska B, Andr\u00e9 F, Fromigu\u00e9 O. Tribbles Pseudokinase 3 Regulation and Contribution to Cancer. Cancers (Basel). 2021;13(8). https:\/\/doi.org\/10.3390\/cancers13081822.","DOI":"10.3390\/cancers13081822"},{"key":"1820_CR118","doi-asserted-by":"publisher","first-page":"109581","DOI":"10.1016\/j.intimp.2022.109581","volume":"114","author":"A Arif","year":"2023","unstructured":"Arif A, Alameri AA, Tariq UB, Ansari SA, Sakr HI, Qasim MT, et al. The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer. Int Immunopharmacol. 2023;114:109581. https:\/\/doi.org\/10.1016\/j.intimp.2022.109581.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"1820_CR119","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cytogfr.2009.07.002","volume":"20","author":"HG Laverty","year":"2009","unstructured":"Laverty HG, Wakefield LM, Occleston NL, O\u2019Kane S, Ferguson MW. TGF-beta3 and cancer: a review. Cytokine Growth Factor Rev. 2009;20(4):305\u201317. https:\/\/doi.org\/10.1016\/j.cytogfr.2009.07.002.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"1820_CR120","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.cmet.2020.03.007","volume":"31","author":"D Liu","year":"2020","unstructured":"Liu D, Zhang P, Zhou J, Liao R, Che Y, Gao M-M, et al. TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation. Cell Metabol. 2020;31(4):726\u2013e408. https:\/\/doi.org\/10.1016\/j.cmet.2020.03.007.","journal-title":"Cell Metabol"},{"key":"1820_CR121","doi-asserted-by":"publisher","unstructured":"Nitti M, Ivaldo C, Traverso N, Furfaro AL. Clinical Significance of Heme Oxygenase 1 in Tumor Progression. Antioxid (Basel). 2021;10(5). https:\/\/doi.org\/10.3390\/antiox10050789.","DOI":"10.3390\/antiox10050789"},{"issue":"8","key":"1820_CR122","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/sj.onc.1203280","volume":"19","author":"JE Green","year":"2000","unstructured":"Green JE, Shibata M-A, Yoshidome K, Liu M-l, Jorcyk C, Anver MR, et al. The C3(1)\/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene. 2000;19(8):1020\u20137. https:\/\/doi.org\/10.1038\/sj.onc.1203280.","journal-title":"Oncogene"},{"issue":"11","key":"1820_CR123","doi-asserted-by":"publisher","first-page":"9492","DOI":"10.3390\/nu7115467","volume":"7","author":"HS Lee","year":"2015","unstructured":"Lee HS. Impact of Maternal Diet on the Epigenome during In Utero Life and the Developmental Programming of Diseases in Childhood and Adulthood. Nutrients. 2015;7(11):9492\u2013507. https:\/\/doi.org\/10.3390\/nu7115467.","journal-title":"Nutrients"},{"issue":"4","key":"1820_CR124","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tem.2009.12.008","volume":"21","author":"KM Godfrey","year":"2010","unstructured":"Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metabolism. 2010;21(4):199\u2013205. https:\/\/doi.org\/10.1016\/j.tem.2009.12.008.","journal-title":"Trends Endocrinol Metabolism"},{"key":"1820_CR125","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcell.2021.682593","volume":"9","author":"A Abbas","year":"2021","unstructured":"Abbas A, Witte T, Patterson WL, Fahrmann JF, Guo K, Hur J, et al. Epigenetic Reprogramming Mediated by Maternal Diet Rich in Omega-3 Fatty Acids Protects From Breast Cancer Development in F1 Offspring. Front Cell Dev Biol. 2021;9:10. https:\/\/doi.org\/10.3389\/fcell.2021.682593.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1820_CR126","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.20182010","volume":"216","author":"S Xing","year":"2019","unstructured":"Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;216(4):847\u201366. https:\/\/doi.org\/10.1084\/jem.20182010.","journal-title":"J Exp Med"},{"issue":"6","key":"1820_CR127","first-page":"1389","volume":"7","author":"L Santiago","year":"2017","unstructured":"Santiago L, Daniels G, Wang D, Deng FM, Lee P. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment. Am J Cancer Res. 2017;7(6):1389\u2013406.","journal-title":"Am J Cancer Res"},{"issue":"6","key":"1820_CR128","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/carcin\/bgs131","volume":"33","author":"FI Huang","year":"2012","unstructured":"Huang FI, Chen YL, Chang CN, Yuan RH, Jeng YM. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion. Carcinogenesis. 2012;33(6):1142\u20138. https:\/\/doi.org\/10.1093\/carcin\/bgs131.","journal-title":"Carcinogenesis"},{"key":"1820_CR129","doi-asserted-by":"crossref","unstructured":"Lima BM, Azevedo ALKd, Giner IS, Gomig THB, Ribeiro EMSF, Cavalli IJ. Biomarker potential of the LEF1\/TCF family members in breast cancer: Bioinformatic investigation on expression and clinical significance. Genet Mol Biology. 2023;46(4):e20220346.","DOI":"10.1590\/1678-4685-gmb-2022-0346"},{"issue":"6","key":"1820_CR130","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1128\/mcb.01487-13","volume":"34","author":"J Rodriguez-Ubreva","year":"2014","unstructured":"Rodriguez-Ubreva J, Ciudad L, van Oevelen C, Parra M, Graf T, Ballestar E. C\/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages. Mol Cell Biol. 2014;34(6):1145\u201357. https:\/\/doi.org\/10.1128\/mcb.01487-13.","journal-title":"Mol Cell Biol"},{"issue":"47","key":"1820_CR131","doi-asserted-by":"publisher","first-page":"eabj0512","DOI":"10.1126\/sciadv.abj0512","volume":"7","author":"S Heino","year":"2021","unstructured":"Heino S, Fang S, L\u00e4hde M, H\u00f6gstr\u00f6m J, Nassiri S, Campbell A, et al. Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas. Sci Adv. 2021;7(47):eabj0512. https:\/\/doi.org\/10.1126\/sciadv.abj0512.","journal-title":"Sci Adv"},{"issue":"1","key":"1820_CR132","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17(1):46. https:\/\/doi.org\/10.1186\/s13045-024-01563-4.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1820_CR133","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/intimm\/dxz001","volume":"31","author":"T Ishihara","year":"2019","unstructured":"Ishihara T, Yoshida M, Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. Int Immunol. 2019;31(9):559\u201367. https:\/\/doi.org\/10.1093\/intimm\/dxz001.","journal-title":"Int Immunol"},{"key":"1820_CR134","doi-asserted-by":"publisher","first-page":"868436","DOI":"10.3389\/fnut.2022.868436","volume":"9","author":"AJF Westheim","year":"2022","unstructured":"Westheim AJF, Stoffels LM, Dubois LJ, van Bergenhenegouwen J, van Helvoort A, Langen RCJ, et al. Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy. Front Nutr. 2022;9:868436. https:\/\/doi.org\/10.3389\/fnut.2022.868436.","journal-title":"Front Nutr"},{"issue":"1","key":"1820_CR135","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11658-025-00694-x","volume":"30","author":"V Marchio","year":"2025","unstructured":"Marchio V, Augimeri G, Morelli C, Vivacqua A, Giordano C, Catalano S, et al. Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer. Cell Mol Biol Lett. 2025;30(1):11. https:\/\/doi.org\/10.1186\/s11658-025-00694-x.","journal-title":"Cell Mol Biol Lett"},{"issue":"16","key":"1820_CR136","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1002\/cncr.25933","volume":"117","author":"RA Murphy","year":"2011","unstructured":"Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer. 2011;117(16):3774\u201380. https:\/\/doi.org\/10.1002\/cncr.25933.","journal-title":"Cancer"},{"issue":"4","key":"1820_CR137","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41417-025-00886-9","volume":"32","author":"A Ibrahim","year":"2025","unstructured":"Ibrahim A, Mohamady Farouk Abdalsalam N, Liang Z, Kashaf Tariq H, Li R, Afolabi O. MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy. Cancer Gene Ther. 2025;32(4):371\u201392. https:\/\/doi.org\/10.1038\/s41417-025-00886-9.","journal-title":"Cancer Gene Ther"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01820-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-026-01820-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01820-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:02:37Z","timestamp":1787338957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-026-01820-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1820"],"URL":"https:\/\/doi.org\/10.1007\/s11912-026-01820-4","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"83"}}